Premium
New drugs affecting lipid metabolism
Author(s) -
Kritchevsky David
Publication year - 1974
Publication title -
lipids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 120
eISSN - 1558-9307
pISSN - 0024-4201
DOI - 10.1007/bf02532133
Subject(s) - chemistry , valeric acid , carbamate , linoleic acid , organic chemistry , lipid metabolism , nicotinic agonist , biochemistry , pharmacology , fatty acid , medicine , acetic acid , receptor
The search for an ideal hypolipidemic agent still is underway. A relatively large number of the newer hypolipemic agents are related to ethyl p‐chlorophenoxyisobutyrate—among them are compounds with the trivial names or designations of SU 13,437; Sah 42‐348; halofenate, treloxinate, S‐8527, and two valeric acid derivatives. Other lipopenic agents, whose modes of action are described, are linoleic acid amides, Colestipol, antidiabetic agents, bis (hydroxyethylthio) 1,10‐decane, pyridinol carbamate, and some nicotinic acid derivatives.